Johnson Matthey signs agreement to sell its Medical Device Components business for US$700m
Johnson Matthey Plc (JM) announces that it has signed a definitive agreement to sell 100% of its Medical Device Components business (MDC) to Montagu Private Equity (Montagu) for cash consideration of US$700 million (£550 million) on a cash free debt free basis.
ArgusEye introduces AugaOne to accelerate downstream bioprocess development
AugaOne sensor system provides specific, real-time, and automated data to reduce mAb process development time New sensor will be exhibited at the Bioprocessing Summit, 18-21 March 2024, booth 66Linköping, Sweden, 21 March 2024:
SolasCure Awarded £405K Innovate UK Biomedical Catalyst Grant to Advance Chronic Wound Care
Funding will be used to further optimize Aurase Wound Gel for future clinical trials SolasCure aims to deliver the first efficacious, cost-effective, and pain-free solution for millions of patients suffering from chronic wounds
Semarion introduces SemaCyte Multiplexing Platform to enhance cell assay data quality and speed during drug discovery
Expansion to SemaCyte Microcarrier platform enables optical barcoding and pooling of adherent cells to augment drug discovery high-content imaging and other screening processes Access available through Semarion’s Early Adopter ProgramCamb
Nuclera Joins Tech Nation’s Future Fifty Program
Nuclera recognized as one of UK’s most exciting growth stage companies Official launch of 2024 cohort taken place at 10 Downing StreetCambridge, UK, 19 March 2024: Nuclera, the biotechnology company enabling rapid protein expres
EFEC in Lingang, Shanghai helping to develop next stages of the Lingang Cambridge Network
In 2019, EFEC worked with Cambridge Network and the Shanghai Lingang Construction and Investment Company to set up the Lingang Cambridge Network, in Lingang, Shanghai. The pandemic then intervened, but EFEC is now back working with the LCN to develop the network and the basis for enhanced Shanghai / Cambridge business interaction and partnerships. EFEC CEO Lily Lin is in the EFEC Lingang…
Growing companies and job seekers encouraged to join popular Jobs & Careers Fair
Cambridge Network, a leading networking organisation in the heart of the Cambridge cluster, announces its upcoming Jobs and Careers Fair, set to take place on 10th May 2024, 12:00 – 16:00 at the Post Doc Centre, Eddington, Cambridge.
Guardtech Group take total cleanroom package to next level with new Isopod Rapid Cleanrooms website
Suffolk-based cleanroom design & build experts launch their fifth new subsite in the space of a year
AstraZeneca to acquire Amolyt Pharma, expanding late-stage rare disease pipeline
Amolyt development portfolio includes Phase III asset with potential to address significant unmet need in patients with chronic hypoparathyroidism Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition, building on company’s succ
Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies
Arrayjet’s patented spot-on-spot microarray screening technology is available for customers to adopt in-house and via Arrayjet’s CRO/CMO services Immunome signs deal to use Arrayjet platform in its in-house screening operationsEdinburgh,
Realising the potential of digital biomarkers in respiratory care
As healthcare progresses into the digital age, digital biomarkers offer tremendous potential for transforming and improving outcomes in respiratory care, particularly for conditions such as COPD and asthma [1].
D-CYPHRing DNA and the power of spit - BioResource at the Cambridge Festival
Most diseases start in childhood, but most health research is carried out in adults. As a result, a big gap exists in our fundamental understanding of how health conditions begin and evolve. An ambitious programme from the NIHR BioResource – the DNA, Children + Young People’s Health Resource, or D-CYPHR – aims to change that. Find out how in our latest talk for the Cambridge Festival.
World’s first IVF clinic Bourn Hall partners with national charity Fertility Network UK to help more employers implement ‘fertility fairness’ in their workplace
The world’s first IVF clinic, Bourn Hall, is joining forces with the UK’s national fertility charity, Fertility Network UK, on their Fertility in the Workplace (FiTW) initiative, which helps firms support staff experiencing fertility struggles.
Access solutions: Reconciling potential for improved patient access with implementation realities
Access to medicine and healthcare services poses persistent challenges, especially in low-income regions with high out-of-pocket expenses.
Lives could be saved from tropical disease with new rapid test
A new test diagnoses patients with melioidosis within hours, rather than days, meaning they can receive the correct antibiotics faster
Nuclera appoints Joseph Bertelsen as Chief Commercial Officer
Key appointment to lead global commercial launch of eProtein Discovery platform
Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement
CRISPR/Cas9 genome editing technology contributes to the expansion of the creation of novel disease model
New Cambridge CF firm advises on sale of Cambridge based Cogentia Healthcare Consulting to Helios Global Group
Alfa Corporate Finance advises on sale of HEOR and market access specialist Cogentia Healthcare Consulting to Helios Global Group
Addenbrooke’s Charity supporters have raised over £100,000 for the new Cambridge Cancer Research Hospital in just one weekend
Earlier this month, Addenbrooke’s Charitable Trust’s (ACT) amazing supporters pulled out all the stops with three magnificent fundraising events raising more than £100,000 for the new Cambridge Cancer Research Hospital.
Shining a light on the future of business: The Guildhall to light up for B Corp Month this March
Between 13 and 20 March, The Guildhall, in Cambridge City’s Market Square, will light up in white, yellow and pink to celebrate B Corp Month, which takes place throughout March.
Harnessing sunlight to digest plastics and a smart fitness device for your brain: meet the 11 start-ups selected from the first Founders at the University of Cambridge Start 1.0 accelerator
Founders at the University of Cambridge welcomes eleven innovative companies to the Start Accelerator 1.0 programme The start-ups, all founded by Cambridge students, alumni and academics, are working on difficult challenges across hardware, life sciences and sustai
Cambridge Wide Open Day returns with ‘Be Curious’ Sci-Tech City-wide event
LEADING science companies and innovation parks will once again open their doors to showcase their contribution to sci-tech innovation when Cambridge Wide Open Day returns for 2024.
Arecor and TRx Biosciences establish research collaboration to develop Oral Glp-1 with enhanced bioavailability
Companies to combine proprietary technologies to formulate an oral semaglutide (GLP-1 receptor agonist) product with enhanced bioavailability Collaboration focused on overcoming the challenges of oral peptide delivery using a novel lipid technology to provide a more convenient t
Exploristics and Exonate announce successful collaboration to enhance clinical trial study design using cloud-based simulation
Exploristics’ cloud-based simulation platform KerusCloud used to enhance study design for Exonate’s upcoming Phase IIb study following successful Phase Ib/IIa studyCambridgeshire and Belfast, UK: Exploristics, a world-leading provider of biosimulat